Annals of Vascular Surgery
Volume 21, Issue 2 , Pages 163-166 , March 2007

Pharmacologic Risk Factor Treatment of Peripheral Arterial Disease is Lacking and Requires Vascular Surgeon Participation

  • Christian Bianchi

      Affiliations

    • Department of Surgery, Loma Linda VA Health Care System, Loma Linda, CA, USA
    • Corresponding Author InformationCorrespondence to: Christian Bianchi, MD, Division Vascular Surgery, Loma Linda VA Healthcare System, 11201 Benton Street (112), Loma Linda, CA 92357
    • ,
  • Valerie Montalvo

      Affiliations

    • Department of Surgery, Loma Linda University Medical Center, Loma Linda, CA, USA
    • ,
  • Harry W. Ou

      Affiliations

    • Department of Surgery, Loma Linda University Medical Center, Loma Linda, CA, USA
    • ,
  • Vicki Bishop

      Affiliations

    • Department of Surgery, Loma Linda VA Health Care System, Loma Linda, CA, USA
    • ,
  • Ahmed M. Abou-Zamzam Jr.

      Affiliations

    • Department of Surgery, Loma Linda University Medical Center, Loma Linda, CA, USA

References 

  1. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine and Biology, and the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Available at http://www.acc.org/clinical/guidelines/pad/index.pdf.
  2. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;11:1317–1324
  3. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510–515
  4. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997;2:221–226
  5. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 1998;18:185–192
  6. Fowkes FGR, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20:384–392
  7. Mc Dermott MM, Mehta S, Ahn H, et al. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med. 1997;12:209–215
  8. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86
  9. Committee CS. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329–1339
  10. Investigators THOPES. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 1998;339:489–497
  11. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360:7–22
  12. Kinikini D, Sarfatu MR, Mueller MT, Kraiss LW. Meeting AHA/ACC secondary prevention goals in a vascular surgery practice: an opportunity we cannot afford to miss. J Vasc Surg. 2006;43:781–787
  13. Bismuth J, Klitford L, Sillesen H. The lack of cardiovascular protection risk factor management in patients with critical limb ischemia. Eur J Vasc Endovasc Surg. 2001;21143–21146
  14. Mc Dermott MM, Han EA, Greenland P, et al. Atherosclerotic risk factor reduction in peripheral arterial disease. Results of a national physician survey. J Gen Intern Med. 2002;17:895–904
  15. Enarnshaw JJ. Clinical outcomes audit in vascular: a shield for our profession. Ann R Coll Surg Engl. 2003;85:256–259
  16. Su H, Gordon M, Roake J, Lewis D. Management of risk factors: a survey of New Zealand vascular surgeons. NZ Med J 2006 Mar 31;119:12-31.
  17. Rehring TF, Stolcpart RS, Sandhoff BG, et al. Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease. J Vasc Surg. 2006;43:1205–1210

 Presented at the 24th Annual Meeting of the Southern California Vascular Society, Temecula, CA, May 5-7, 2006.

PII: S0890-5096(07)00110-0

doi: 10.1016/j.avsg.2007.01.008

Annals of Vascular Surgery
Volume 21, Issue 2 , Pages 163-166 , March 2007

Article Tools